EGFR and neoplasm: At the same time, AKT-PI3K-mTOR/PTEN represents the second signaling hub of the EGFR pathway, being amplified in almost 20% of CRCs.52Multiple oncomirs and tumor-suppressor microRNAs interact and control functioning of this cascade under both physiological circumstances and malignancy.